Seeing Is Believing
with an average price target of $-3.6. This is a potential upside of $-5.42 (-297.8%) from yesterday's end of day stock price of $1.82.
Reneo Pharmaceuticals's activity chart (see below) currently has 18 price targets and 17 ratings on display.
Analysts average stock forecasts to be materialized ratio is 69.44% with an average time for these price targets to be met of 180.33 days.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 13-May-2024. First documented stock forecast 03-May-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$30
1 years 4 months 28 days ago
(13-May-2024)
2/3 (66.67%)
$15.8 (111.27%)
47
Hold
$1.8
$-0.02 (-1.10%)
$24
1 years 9 months 27 days ago
(15-Dec-2023)
1/2 (50%)
$0.38 (26.76%)
145
Hold
$15
1 years 9 months 27 days ago
(14-Dec-2023)
1/1 (100%)
$-19.9 (-57.02%)
630
Hold
$4
$2.18 (119.78%)
$25
1 years 9 months 28 days ago
(13-Dec-2023)
7/7 (100%)
$-9.4 (-70.15%)
189
Buy
$30
$28.18 (1548.35%)
$30
2 years 1 months 4 days ago
(07-Sep-2023)
3/3 (100%)
$-41.1 (-57.81%)
71
What is RPHM (Reneo Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on RPHM (Reneo Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on RPHM (Reneo Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on RPHM (Reneo Pharmaceuticals)?
Which analyst is the currently most bullish on RPHM (Reneo Pharmaceuticals)?
Which analyst is the currently most reserved on RPHM (Reneo Pharmaceuticals)?